【Call for Applications】Call for Applications for the 114th National Pharmaceutical Science and Technology Research and Development Award Program has begun
Hello, teachers!
To encourage and support innovation and breakthroughs in the field of pharmaceutical technology, we sincerely invite you to participate in the Pharmaceutical Technology Research and Development Incentive Program.
This program aims to encourage researchers in the fields of pharmaceuticals, medical devices and manufacturing technologies to promote the development of pharmaceutical technology and enhance international competitiveness through innovative and high-quality research results.
The relevant instructions are as follows:
First, the National Pharmaceutical Science and Technology Research and Development Award Program is divided into three categories: pharmaceuticals, medical devices, and manufacturing technology.
To be eligible for the registration, you must have a medical device license issued by the Ministry of Health and Welfare, and the issue date must be after January 1, 2012.
You need to select one of the application conditions.
If an organization has two or more products that meet the registration requirements, they may register repeatedly.
Please compile the registration information and attach six copies of the paper version and the electronic version to the receiving unit.
The application period is from the announcement date to 5:00 p.m. on June 30, 2025 (postmark is the proof).
All review processes are written reviews, divided into two stages: preliminary review and re-review.
The shortlist will be announced on the event website in September 2015, and the award ceremony is scheduled for November 2015.
Related Information:
Accepting unit: National Pharmaceutical Science and Technology Research and Development Award Working Group
Contact number: (02)8913-1111#512 Ms. Xing
Mailing address: 8F, No. 205-2, Section 3, Beixin Road, Xindian District, New Taipei City
Email: chilling89228@topwin.com.tw
Official website: https://sites.google.com/view/tw-nobel-medtech/%E9%A6%96%E9%A0%81
